A pharmacokinetic study to assess age-related and intra-patient differences in the pharmacokinetics of intravenous pegylated liposomal doxorubicin in female cancer patients.
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2013
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 05 Jan 2011 New trial record